Intravenous immunoglobulin for the treatment of childhood encephalitis
Encephalitis is a syndrome of neurological dysfunction due to inflammation of the brain parenchyma, caused by an infection or an exaggerated host immune response, or both. Attenuation of brain inflammation through modulation of the immune response could improve patient outcomes. Biological agents su...
المؤلفون الرئيسيون: | Iro, M, Martin, N, Absoud, M, Pollard, A |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Cochrane Collaboration
2017
|
مواد مشابهة
-
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
حسب: Hill, M, وآخرون
منشور في: (2023) -
Childhood encephalitis in the United Kingdom - epidemiology, trends in hospital admissions and the role of intravenous immunoglobulin
حسب: Iro, M
منشور في: (2018) -
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
حسب: Iro, MA, وآخرون
منشور في: (2024) -
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
حسب: Simon Nadel, وآخرون
منشور في: (2023-11-01) -
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
حسب: Mildred A Iro, وآخرون
منشور في: (2024-04-01)